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GuanidineMembrane-bound respiratory complex I in inside-out submitochondrial particles (SMP) catalyzes both superoxide
and hydrogen peroxide formation in NADH- and/or succinate-supported reactions. At optimal NADH concentration
(50 μM), the complex I-mediated process results in a formation of two superoxide anions and H2O2 as the reaction
products in approximately 0.7 ratio. Almost the same ratio is found for puriﬁed complex I (0.6) and for the aerobic
succinate-supported reverse electron transfer reaction. Superoxide production is depressed at high,more physiolog-
ically relevant NADH concentrations, whereas hydrogen peroxide formation is insensitive to the elevated level of
NADH. The rates of H2O2 formation at variable NAD
+/NADH ratios satisfactorily ﬁt the Nernst equation for a single
reactive two-electron donor component equilibrated with ambient midpoint redox potential of −347 mV (0.13
NAD+/NADH ratio, pH 8.0). Half-maximal superoxide production rate proceeds at signiﬁcantly higher NAD+/
NADH ratio (0.33). Guanidine strongly stimulates NADH-supported hydrogen peroxide and superoxide production
at anyNADHconcentration andactivatesNADH:ferricyanide and inhibitsNADH:hexaammineruthenium(III) reduc-
tase activitieswhile showing no effects onNADH oxidase of SMP. In the low range of NADH concentration, superox-
ide production rate shows a simple hyperbolic dependence on NADH with apparent KmNADH of 0.5 μM, whereas
sigmoidal dependence of hydrogen peroxide production is seen with half-maximal rate at 25 μMNADH.We inter-
pret the data as to suggest that at least two sites participate in complex I-mediatedROSgeneration: FMNH– that pro-
duces hydrogen peroxide, and an iron–sulfur center (likely N-2) that produces superoxide anion.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The maximal relative contribution to the total cellular hydrogen
peroxide production from various subcellular fractions of rat liver
have been approximated as 15%, 45%, 35%, and 5% for mitochondria,
microsomes, peroxisomes, and cytosolic enzymes, respectively [1]. Up
to 2% of oxygen consumed by rat liver or pigeon heart mitochondria
respiring in State 4 is converted to hydrogen peroxide, and this amount
is drastically decreased at State 3 or upon uncoupling [2,3]. Thus under
certain physiologically relevant conditionsmitochondria are thought to
contribute signiﬁcantly to the steady-state level of hydrogen peroxide
in cells [4–6].
About half of the total ROS (superoxide anion andhydrogen peroxide)
produced by heart mitochondria at high NADH/NAD+ ratio can be
accounted for as being generated by the respiratory chain components
(complex I and complex III) [7,8]. The rest is producedby soluble enzymes
of the matrix, mostly by dihydrolipoamide dehydrogenase (DLDH)eroxide anion; ROS, reactive ox-
olipoamide dehydrogenase; HP,
hexaammineruthenium(III); Q1,
A, bovine serum albumin; FP,
gradov).
l rights reserved.[8–11]. Inside-out bovine heart submitochondrial particles (SMP)
essentially free of other than the respiratory chain ROS generators
catalyze superoxide production during coupled respiration with
either NADH or succinate at the rate corresponding to about 0.1% of
oxygen consumed by cytochrome oxidase [12]. Inhibitory analysis
suggests that the major part of superoxide produced by the respira-
tory chain (up to 70%) is generated by complex I [12].
Mammalian complex I is a gigantic iron–sulfur-ﬂavo-lipoprotein com-
posed of 44–45 different subunits [13,14] bearing at least ten redox com-
ponents (FMN, eight iron–sulfur clusters, bound ubiquinone) [15]. As a
component of the respiratory chain, the enzyme catalyzes reversible
proton-translocating NADH:ubiquinone oxidoreduction, thus operating
as an energy-transducing device (coupling site 1) [15]. All known redox
components are buried in the hydrophilic domain of the enzyme exposed
to the matrix space [16,17].
The mechanism of ROS production by complex I is of considerable
interest because cellular oxidative stress is conventionally believed to
be a major cause of a number of pathologies and the aging process
[18–20]. Besides their biomedical importance, studies on ROS produc-
tion by complex I may provide information on the arrangement and
reactivity of its speciﬁc redox components. Which particular compo-
nent(s) in the NADH-ubiquinone region of the respiratory chain
directly interact(s) with oxygen is still debated: NAD•-radical [21],
FMN [22–25], ubisemiquinone [26], and iron–sulfur clusters N-1a
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production. Also, a single site [25], two-sites [29], and dynamically
shifted two sites/species [30] models have been proposed by different
research groups.
An interesting feature of superoxide generation catalyzed by com-
plex I bound to the coupling membrane in the presence of either
NADH or succinate (via energy-linked reverse electron transfer) is
that the reaction is strongly inhibited if the concentration of NADH
increases above “optimal” with an apparent “Ki” in the μmolar range
[12]. When hydrogen peroxide production was detected as ROS pro-
duced by complex I in the presence of superoxide dismutase (SOD),
less inhibition by elevated NADH was observed. We thought that this
apparent discrepancy could be explained if both superoxide and hydro-
gen peroxide are produced by complex I, and only the former process is
inhibited by high concentrations of NADH. This paper describes experi-
ments supporting this hypothesis. The effects of guanidine, a ligand
known to strongly stimulate NADH:ferricyanide reductase activity of
the enzyme [31,32] and to increase the ﬂavin radical seen in complex
I [33], on ROS production are also described. Possible mechanisms
(sites) of complex I-oxygen interaction are discussed.
2. Materials and methods
Bovine heart SMP were prepared [34], coupled by treatment with
oligomycin, and activated [35] according to published protocols. Bovine
heart complex Iwas puriﬁed according toHateﬁ et al. [36]. All the assays
were done at 30 °C. Protein content was determined by the biuret
procedure.
Trypsin-treated SMPwere prepared as follows. Tenmg of trypsin was
dissolved in 0.5 ml of the standard reaction mixture (see below), and
0.44 ml of this solutionwas added to 4 ml of SMP (22 mg/ml) suspended
in the samemedium (0.1 mg of trypsin permg of SMP protein). Themix-
turewas incubated on ice for 30 min. Trypsin inhibitor (44 mgof protein)
was then added and incubated for 10 min. The mixture was diluted to
80 ml, and the SMP were sedimented (1 h at 30 000 g), washed with
80 ml of the standard mixture, suspended in 3 ml of the same medium,
and stored as 0.25 ml samples in liquid nitrogen.
Hydrogen peroxide formation was measured photometrically
with Amplex Red (20 μM) as a formation of resoruﬁn, ε572=
54 mM−1 ∙ cm−1 [37], in standard reaction mixture composed
of 0.25 M sucrose, 50 mM Tris-Cl (pH 8.0), and 0.2 mM EDTA,
supplemented with 5 μM rotenone (if indicated), horseradish
peroxidase (HP, 2 units/ml), and bovine erythrocyte superoxide
dismutase (SOD, 6 units/ml). Superoxide production was monitored
as SOD-sensitive acetylated cytochrome c (10 μM) reduction at 550 nm
(ε550=20 mM−1 ∙cm−1) [38]. Increasing cytochrome c concentration
up to 30 μM did not increase its SOD-sensitive reduction, but it did
increase the SOD-insensitive reaction. SOD-insensitive components of
acetylated cytochrome c reduction during aerobic oxidation of succinate
or NADH were less than 25%. Addition of rotenone decreased the
SOD-insensitive fraction of NADH-supported cytochrome c reduction to
5–7%. The amount of H2O2 determined by Amplex Red assay is the sum
of the speciﬁcally produced H2O2 plus H2O2 resulting from dismutation
(SOD-catalyzed and spontaneous) of two speciﬁcally produced superox-
ide radicals. We noted that some samples of HP display superoxide
dismutase activity (intrinsic or due to contaminations), which might
result in overestimation of the speciﬁc H2O2 production if both hydrogen
peroxide and superoxide were the reaction products. Thus, the speciﬁc
hydrogen peroxide-producing activity H2O2(speciﬁc) was calculated as
follows:
H2O2ðspecificÞ ¼ H2O2ðtotalÞ–2O
·
2
where H2O2(total) is the amount of hydrogen peroxide assayed with
Amplex Red in the presence of SOD, and O
·
2 is the amount of superoxidedetermined as SOD-sensitive acetylated cytochrome c reduction. It has
been shown that under certain conditions HP is capable of NADH
oxidation-related ROS production in the process which is prevented by
SOD [39]. Thus the experiments were conducted to assure that no
undesired, catalyzed by any other than complex I preparation ROS pro-
duction proceeded during the assays under the conditions employed.
Fig. 1A demonstrates that no resoruﬁn formation occurred during assay
period unless total (superoxide plus hydrogen peroxide) ROS production
was initiated by the addition of SMP. The reaction proceeded as
zero-order process and the rates were calculated as the slope of actual
tracings.Whenvery lowNADHconcentrationswereused, the registration
curve deviated from linearity in time-dependent manner due to NADH
decrease and NAD+ increase. However, the initial slope of the actual
registration curve could be easily determined if proper amount of the
enzyme and time resolution scale were used. Fig. 1B shows analogous
representative control experiments where SOD-sensitive acetylated
cytochrome c reduction was assayed as a measure of complex I catalyzed
superoxide production.
NADH:acceptor oxidoreductase activities were determined in
the standard reaction mixture supplemented with the proper electron
acceptor as a decrease in NADH absorption at 340 nm (ε340=
6.2 mM−1 ∙cm−1) or as a decrease in ferricyanide absorption at
420 nm (ε420=1.0 mM−1 ∙cm−1). The speciﬁc activities are expressed
as 2ē-equivalents, i.e. the amount of NADH oxidized. The results
presented are average values of at least three independent assays.
Amplex Red was from AnaSpec, Inc. (U.S.A.); ﬁne chemicals: nu-
cleotides; trypsin (type XIII from bovine pancreas); trypsin inhibitor
(type II-S from soybean); horseradish peroxidase (type II); SOD
from bovine erythrocytes; partially acetylated cytochrome c from
equine heart; alcohol dehydrogenase from bakers yeast; Q1; and
inhibitors were from Sigma-Aldrich (U.S.A.). Other chemicals of
highest purity available were from local suppliers.3. Results
3.1. Experimental system
Inside-out bovine heart SMP and complex I puriﬁed according to
Hateﬁ's procedure were used throughout this study, and total hydro-
gen peroxide production in the presence of superoxide dismutase
measured by Amplex Red assay or superoxide production measured
as SOD-sensitive acetylated cytochrome c reduction were used to
quantify the total and particular species of ROS. It has been shown
that a considerable fraction of NADH-supported H2O2 formation by
permeabilized heart mitochondria can be accounted for by hydrogen
peroxide generation by DLDH located in matrix [7,8], hence it seemed
worthwhile to determine whether SMP prepared by our routine pro-
cedure [34,35] contain any DLDH either as contamination or as intrin-
sic membrane-bound form of the enzyme. DLDH activity is known to
be very sensitive to trypsinolysis [40], and tryptic digestion was used
to detect possible presence of DLDH activity in our standard SMP. The
data presented in Table 1 show that: (i) SMP indeed contain some
lipoamide reductase activity, which was completely destroyed by
controlled tryptic digestion; (ii) in the absence of activating ammoni-
um [41], the contribution from DLDH to the NADH-supported hydro-
gen peroxide formation determined as the activity insensitive to
NADH-OH, a speciﬁc inhibitor of complex I [42], was less than 10%;
(iii) under the conditions employed (see Materials and methods sec-
tion) tryptic digestion did not signiﬁcantly affect complex I activity.
Separate experiments showed that tryptic digestion resulted in a de-
crease in coupling efﬁciency. The respiratory control ratio with NADH
as the substrate before and after trypsin treatment was 8.3 and 3.3,
respectively. The data shown in Table 1 proved that the standard
SMP as prepared in our laboratory are a simple and reliable system
for studies on ROS production mediated by the respiratory chain
Fig. 1. Representative samples of the total hydrogen peroxide formation (A, Amplex Red assay) and superoxide generation (B, acetylated cytochrome c assay, SOD (6 units/ml) was
added where indicated). The reactions were initiated by the addition of SMP (100 μg/ml, where indicated) to the standard reaction mixture. Curves 1 and 2, 50 and 500 μM NADH,
respectively, were added to the assays. Curves 3: A, 500 μMNADH, SOD (6 units/ml), no SMPwere added; B, SOD (6 units/ml) was present in the assay mixture before SMP addition.
An increase of SOD amount did not change the pattern shown.
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SMP (no treatment by trypsin).
3.2. H2O2 andO
·
2 generation by membrane-bound and puriﬁed complex I
The total NADH-supported ROS production catalyzed by rotenone-
treated SMP at optimal (for superoxide generation) NADH concentra-
tion (50 μM) was about 4 nmol NADH oxidized/min per mg of
protein, the activity corresponding to about 0.25% of their catalytic
capacities in the respiratory chain-mediated NADH oxidase activity.
The membrane-bound (SMP) and puriﬁed complex I were capable
of both superoxide and hydrogen peroxide formation, and parti-
tioning of either species was dependent on NADH concentration.
Fig. 2 summarizes the data on NADH dependence of superoxide
and hydrogen peroxide production by SMP and puriﬁed complex I
in the presence of rotenone, conditions where any reduced compo-
nent of complex I could mediate one- or two-electron reduction of
oxygen, except for bulk ubiquinol and N-2-associated semiquinones.
The pattern shown in Fig. 2A (superoxide production) agrees with
previously reported data [12] on inhibitory effect of high NADH con-
centrations, whereas essentially no inhibition was seen when hydro-
gen peroxide production was determined in the same concentration
range of NADH (Fig. 2B). The data shown in Fig. 2, panels B and C,
may appear contradictory: no hydrogen peroxide formation atTable 1
Effect of tryptic digestion on catalytic activities of SMP.
Activity (nmol/min per mg)a
pH 8.0, 30 °C
Standard SMP Trypsin-treated SMP
NADH-oxidaseb 1600±150 1450±120
NADH:Q1-reductasec 900±70 850±50
Lipoamide reductased 50±5 Undetectable
Total hydrogen peroxide formatione 4.0±0.2 4.0 ±0.15
+ NH4Clf 4.6±0.3 3.7±0.4
+ NADH-OHg 0.37±0.05 0.27±0.03
+ NADH-OHg, + NH4Clf 1.85±0.15 0.65±0.07
a Averaged data from at least three assays performed with the same batch of SMP.
b NADH (100 μM)as the substrate, 0.2 μg/ml gramicidin D in the standard assaymixture.
c NADH (100 μM) and Q1 (80 μM) as the substrates, 0.2 μg/ml gramicidin D and
antimycin A (1 μg/ml) in the standard assay mixture.
d NADH (100 μM) and lipoamide (1 mM) as the substrates.
e In the presence of 100 μMNADH and 5 μM rotenone, assayed with Amplex Red.
f 30 mM NH4Cl was added to the standard assay mixture
g PreincubatedwithNADH-OH(5 nmol permgof protein) at 23 °C for 1 min before assay.NADH concentration below 3 μM is documented in panel C, whereas
a hyperbola-like curve for the same activity is shown in panel B.
This apparent inconsistency is clariﬁed by the more detailed titration
pattern for low NADH concentration range as shown in Fig. 3.
At low NADH (≤3 μM) only superoxide was produced, whereas
more than 60% of the total reaction product appeared as hydrogen
peroxide at higher (≥50 μM) NADH concentrations. The same pat-
tern was seen for puriﬁed complex I (Fig. 2D) suggesting that under
the conditions employed no other than complex I enzymes contribut-
ed to the overall ROS production by the SMP.
Complex I, an intrinsic component of the proton motive force-
generating respiratory chain, is capable of rotenone- and uncoupler-
inhibited ROS production when bulk ubiquinol provided by complex
II during coupled succinate oxidation serves as the substrates
for energy-dependent quinol:oxygen oxidoreduction [43] (energy-
linked reverse electron transfer [44]). This reaction is of particular in-
terest for studies on complex I-catalyzed ROS production because
it proceeds under conditions where the active FMN-containing
substrate-binding site of the enzyme is free of nucleotides. Table 2
shows relative contribution of the reaction products to ROS formation
during coupled respiration with succinate and NADH. Both superox-
ide (about 65%) and hydrogen peroxide (about 35%) were produced
during the reverse operation of complex I (line 1). An improvement
in coupling efﬁciency by BSA signiﬁcantly increased, as expected,
total ROS production and, more interestingly, changed the proportion
between the reaction products (line 2). Almost the same total
ROS production was seen during succinate- (reverse) and NADH-
supported (forward) operation of complex I (line 2 and 3). Rotenone
stimulated the NADH-supported reaction and also increased the rela-
tive contribution of hydrogen peroxide. A general pattern emerging
from the data shown in Table 2 is that the higher reduction level of
complex I was reached the higher the rate of total ROS production
was seen and the larger relative contribution of hydrogen peroxide
was observed.
3.3. Redox titration of NADH-supported ROS generation
To gain further insight into quantitative aspects H2O2 and O
·
2 as
the reaction product, the speciﬁc rates of generation of each species
as a function of NAD+/NADH ratio were measured (Fig. 4). The opti-
mal (for superoxide production) concentration of (NAD+ + NADH)
pool (50 μM, see Fig. 2A) was used in the titration experiments. H2O2
production was signiﬁcantly more sensitive to an increase in NAD+/
NADH ratio than that of superoxide formation: half-maximal rates of
Fig. 2. NADH-supported superoxide and hydrogen peroxide production by themembrane-bound (A–C) and puriﬁed complex I (D) as a function of NADH concentration. All the activities
weremeasured in the standard reactionmixture supplementedwith 5 μMrotenone. A, superoxide generationmeasured as SOD-sensitive acetylated cytochrome c reduction. B, hydrogen
peroxide production measured as the difference between total resoruﬁn formed and superoxide determined as in A (see Materials and methods). C, contribution of superoxide
(open bars) and hydrogen peroxide (gray bars) to the total ROS production. D, the same as C, ROS generation by puriﬁed complex I was determined as in A and B, respectively.
The reactions were initiated by the additions of 100 (SMP, A–C) or 30 (complex I, D, right ordinate) μg of protein per ml of the assay mixture and the initial rates were measured.
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tios of 0.13 and 0.33, respectively. The titration curve for H2O2 produc-
tion satisfactory ﬁtted the Nernst equation corresponding to apparent
midpoint potential of a two-electron donor with midpoint potential of
−347 mV (Fig. 4A, closed circles). The titration curve for superoxide
production could not be ﬁtted by the Nernst equation (Fig. 4B, closed
circles). Note should bemade that the data shown in Fig. 4 are certainly
not classical redox titration curves. The dissociation constants for
oxidized and reduced NAD binding to the oxidized and reduced
enzyme are the parameters that, in addition to true redox equilibrium,Fig. 3. NADH-supported superoxide and hydrogen peroxide production bymembrane-bound (
peroxide production (○) were measured as in Fig. 2.determine the concentration of the enzyme capable of uni- or divalent
reoxidation by oxygen. These binding constants were shown to be
dependent on the reduction of the enzyme [45].
3.4. Effect of guanidine on complex I-mediated ROS production
We have claimed previously that guanidine increases NADH-
supported superoxide production [12] similar to its stimulatory effect
on the NADH:ferricyanide reductase activity [31,32]. This phenomenon
was further investigated. Three-fold increase in NADH-supportedA) and puriﬁed complex I (B) at low NADH concentrations. Superoxide (●) and hydrogen
Table 2
Superoxide and hydrogen peroxide production by SMP during coupled NADH and succinate oxidation.
Substrate Product formation ratea (2ē-eqv•109/min per mg of protein)
Superoxide (A) Hydrogen peroxide (B) A+B A/B ratio
1. Succinate (5 mM)b 0.9±0.1 0.5±0.1 1.4±0.1 1.90±0.10
2. + BSA (1 mg/ml)c 1.0±0.1 1.2±0.2 2.2±0.2 0.70±0.15
NADH (50 μM)
3. – rotenone 1.1±0.1 1.2±0.2 2.3±0.2 0.85±0.05
4. +5 μM rotenone 1.8±0.2 2.8±0.3 4.6±0.3 0.65±0.05
a Averaged data from at least three assays with the same batch of SMP.
b Rotenone-sensitive ROS production, i.e. complex I-catalyzed activities are documented. The succinate-supported, rotenone-insensitive activities (complex II+complex III
contribution), 0.36±0.06 (2ē-eqv•109/min per mg of protein), were subtracted from the actually observed rates of superoxide or hydrogen peroxide formation.
c BSA was added to increase coupling efﬁciency. The respiratory control ratio was 4.5±0.5 and 7.8±0.5 in the absence and presence of BSA, respectively.
450 V.G. Grivennikova, A.D. Vinogradov / Biochimica et Biophysica Acta 1827 (2013) 446–454superoxide production by complex I in SMP was observed at high
(saturating) guanidine chloride concentration (Fig. 5A). An increase
in ROS production depends hyperbolically on guanidine concentrations
with half-maximal stimulation at 20 mM (results not shown). Three
samples of guanidine chloride obtained fromdifferent suppliers showed
identical effects. The stimulation was not due to the well-known general
chaotropic properties of guanidine salts: guanidine isothiocyanate
showed the same effect as did the chloride salt. A guanidine derivative,
metformin, an antidiabetic drug that is known to inhibit complex I activ-
ity [46] at 50 mM concentration, showed only weak (1.4-fold) stimula-
tion on the NADH-supported superoxide production catalyzed by the
membrane-bound complex I (SMP) in the presence of rotenone.
Guanidine changed neither overall NADH oxidase nor NADH:qui-
none reductase activities, whereas it altered complex I reactivity
with artiﬁcial electron acceptors and oxygen (Table 3). It inhibited
NADH:HAR reductase and stimulated ferricyanide reduction and
ROS production. The same stimulation (3-fold) of ferricyanide and ox-
ygen univalent reduction was evident, whereas a smaller increase in
H2O2 production (1.5-fold) was observed (Table 3 and Fig. 5). We
were unable to evaluate the effect of guanidine on rotenone-sensitive
succinate-supported ROS production (reverse electron transfer) be-
cause guanidine strongly inhibited aerobic succinate-supported NAD+
reduction catalyzed by tightly coupled SMP. The latter phenomenon
was, at least partially, due to the inhibitory effect of guanidine on succi-
nate oxidase (Table 3, line 7).
Next the effect of guanidine on superoxide and hydrogen peroxide
production by puriﬁed complex I at various NADH concentrations
was tested (Fig. 6A–C). Both hydrogen peroxide and superoxide pro-
duction were stimulated by guanidine. Only superoxide formation
was analyzed by the standard kinetic approach, i.e. double-reciprocalFig. 4. NADH-supported ROS production by SMP as a function of NAD+/NADH ratio. Hydrogen
(NAD++NADH) in the absence (●) and in the presence (○) of 50 mM guanidine chloride. Co
reactive redox components equilibrated with ambient midpoint potentials set by NAD+/N
-334 mV. The activities were normalized to those observed in the absence of NAD+. The additio
ized activities.plot constructed for very low concentrations of NADH (ascending
parts of the curves shown in Fig. 6A). The linear dependencies shown
in Fig. 6B suggest that guanidine increased the maximal rate without
notable effect on apparent KmNADH. No such simple analysis could be
done for hydrogen peroxide formation because the dependence on
NADH was not hyperbolic, as is shown in Fig. 3.
Finally, the effect of guanidine on the redox dependence of ROS
production was assessed (Fig. 4, A and B, open symbols). Guanidine
shifted the redox titration curves for both superoxide and hydrogen
peroxide formation to more positive apparent redox potentials.
Half-maximal rates of ROS production in the presence of guanidine
were at NAD+/NADH ratios of 0.42 for H2O2 and 2.54 for O
·
2 produc-
tion versus 0.13 for H2O2 and 0.33 forO
·
2 production in the absence of
guanidine.
4. Discussion
4.1. Experimental system
The speciﬁc activities reported in numerous publications on the
mitochondrial ROS production determined either on protein or par-
ticular component content basis are highly variable. Besides natural
species and tissue speciﬁcity [47–49], the type of preparation used
for the assays seems to be important. Several experimental systems
for studies of ROS generation by complex I are available. Isolated
mitochondria generate H2O2 in State 4, i.e. under conditions when the
intramitochondrial pyridine nucleotide pool is highly reduced. Quantita-
tive analysis of complex I-mediated superoxide and hydrogen peroxide
production by intact mitochondria is hampered by the presence of gluta-
thione reductase, glutaredoxins, glutathione peroxidase system, andperoxide (A) and superoxide production (B) were measured as in Fig. 2 at 50 μM pool of
ntinuous lines, theoretical curves corresponding to the Nernst equation for two-electron
ADH ratio equal to: A, ~347 mV (closed symbols), -331 mV (open symbols), and B,
ns of 100 mMethanol and alcohol dehydrogenase (250 units/ml) did not change normal-
Fig. 5. Effect of guanidine chloride on superoxide (A) and hydrogen peroxide production (B) by SMP. The speciﬁc activities were determined as in Fig. 2 in the absence (●) and in
the presence (○) of 50 mM guanidine chloride.
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dehydrogenases, particularly DLDH [7,9–11], signiﬁcantly contribute to
the overall mitochondrial ROS production. Puriﬁed preparations of com-
plex I [36,52,53] seemmuch better suited for studies on its catalytic, par-
ticularly ROS-generating activity. However, no simple techniques are
available to impose proton motive force for simulation of “physiological-
ly” relevant conditions when puriﬁed detergent-dispersed complexes I
are used. Also, the detergents used for puriﬁcation of complex I may
alter its catalytic activities [54,55]. To compromise between extremely
complex (mitochondria) and simplest well deﬁned (puriﬁed complex
I) experimental systems, inside-out coupled SMP [34,35] are
routinely used in our studies on complex I. Here we showed that
our “standard” SMP retain some DLDH activity (Table 1), despite ex-
tensive dilution, washing, and Sephadex column ﬁltration during
the preparation. This ﬁnding is indicative of the presence of
membrane-bound DLDH in mitochondria. SMP-bound hydrogen
peroxide generating activity was increased 5-fold by ammonium
(Table 1), this being qualitatively similar to the phenomenon previ-
ously described for the soluble enzyme [11,41]. Whether other proper-
ties of themembrane-boundDLDH are the same as those of free soluble
protein remains to be established. SMP completely devoid of DLDH ac-
tivity can be easily prepared (Table 1) and used for DLDH reconstitution
studies, which are currently underway in our laboratory. In the absence
of activating ammonium, the contribution of other than complex I gen-
erating sources to the overall production catalyzed by either standard orTable 3
Effect of guanidine chloride on SMP activities.
Activity, (2ē-eqv•109/min per mg) pH 8.0, 30 °C
control (A) +50 mM guanidine chloride (B) B/A
1. NADH-oxidasea 1650±130 1640±140 0.9
2. NADH:Q1-reductasea 900±70 810±50 0.9
3. NADH:HAR-reductaseb 2600±130 1900±70 0.7
4. NADH:
ferricyanide-reductasec
4100±500 12500±1500 3.0
5. Superoxide formationd 1.8±0.1 5.0±0.2 2.8
6. Hydrogen peroxide
formationd
2.7±0.2 4.1±0.2 1.5
7. Succinate oxidasee 830±70 580±50 0.7
a Assayed and average as described in Table 1.
b NADH (100 μM) and HAR (0.5 mM) as the substrates, 5 μM rotenone in the standard
assay mixture.
c NADH (100 μM) and ferricyanide (0.5 mM) as the substrates, 5 μM rotenone in the
standard assay mixture.
d NADH (50 μM) as the substrate, 5 μM rotenone in the standard assay mixture.
e Potassium succinate (5 mM) as the substrate, 0.2 μg/ml gramicidin D in the standard
assay mixture.trypsin-treated SMP was less than 10% as evident from 90% inhibition
by complex I-speciﬁc NADH-OH (Table 1).
4.2. Hydrogen peroxide and superoxide generation by complex I
Both, H2O2 andO
·
2 are produced by complex I, and the partitioning
of the reaction products depends on NADH concentration (Fig. 2).
Only superoxide was generated by the membrane-bound and puri-
ﬁed complex I at low NADH (1–3 μM) in a reaction with apparent
Km
NADH of 0.5 μM (data for puriﬁed complex I, Fig. 6B), a value that is
signiﬁcantly higher than that (0.05 μM, at pH 7.5, 32 °C) reported for
superoxide production by bovine heart complex I puriﬁed by a different
isolation procedure [24]. Since the rate of ROS production by complex I
is much slower than the enzyme capacity in reactions with electron
acceptors other than oxygen, it is safe to assume that all its redox com-
ponents are in true equilibrium during steady-state NADH:oxygen
oxidoreduction. The apparent Km for the substrate-electron donor in
the reaction catalyzed by any oxidoreductase that contain several line-
arly arranged redox components depends on thermodynamic gap
between the primary electron acceptor and the component reacting
with the substrate-oxidant; the larger the gap is, the lower Km is
expected to be [56]. Very low apparent KmNADH in ROS generation [24,
this paper] as comparedwith those reported for reactionswith other ar-
tiﬁcial electron acceptors [43] suggests that a component with signiﬁ-
cantly more positive potential than that of the primary acceptor
(FMN) is the actual donor for one-electron reduction of oxygen. The
data on the redox titration of superoxide production (Fig. 4B) show
that a substantial rate (about 20% of the maximal) was observed at
NAD+/NADH ratio as high as 10:1, corresponding to the ambient
redox potential of−290 mV at pH 8.0. This value is much higher than
that for the FMN/FMN– couple (about−370 mV at pH 8.0) in complex
I [33]. At present, we are unable to unambiguously identify a compo-
nent responsible for superoxide production. The iron–sulfur center
N-2 seems to be a likely candidate in light of the large thermodynamic
gap between the primary electron acceptor (FMN) and the ﬁnal elec-
tron donor (see above). An obvious question arises: what is the
explanation for the inhibitory effect of high NADH concentrations on
superoxide production if the iron–sulfur cluster located far away from
NADH binding site [16,17] is the electron donor? It has been shown
recently that eukaryotic complexes I bear an allosteric nucleotide
(ATP)-binding site that, when ﬁlled, strongly stimulates NADH:HAR
reductase activity [57]. We hypothesized that binding of ATP at this
site modulates the redox potential of iron–sulfur center N-2 and/or its
accessibility for HAR [57] (see a different interpretation of the phenom-
enon in Ref. [58]). The stimulatory effect of ATP is completely eliminat-
ed by increased concentration of NADH, thus suggesting that NADH can
bind to complex I at a site different from its conventional “substrate-
Fig. 6. Effect of guanidine chloride on superoxide (A and B) and hydrogen peroxide production (C) by puriﬁed complex I. The speciﬁc activities were determined as in Fig. 2 in the
absence (●) and in the presence (○) of 50 mM guanidine chloride. B, double reciprocal plot for ascending part of the curves shown in A (low concentrations of NADH).
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redox potential and/or accessibility of N-2 to oxygen. Interestingly,
ferricyanide reductase activity of Paracoccus denitriﬁcans NDH-1, a
prokaryotic homolog of complex I that is devoid of the allosteric nucle-
otide binding site [57], shows only weak inhibition by NADH [59]. The
proposal on center N-2 as the source of superoxide is in apparent
contradiction with the data of Galkin and Brandt, who have shown
that a mutation of Yarrowia lipolytica complex I that eliminated the
N-2 EPR signal did not inhibit its superoxide generating activity [60].
It should be noted that the mutation may make N-2 EPR-silent though
still capable of oxygen reactivity. Also, other than N-2 iron–sulfur
center(s), except, perhaps, N-1awithmuch lowermidpoint redox poten-
tial [61], can be considered as the potential source of superoxide following
the reasoning discussed above.
The kinetics and “thermodynamics” of hydrogen peroxide genera-
tion were different from those of superoxide production. The difference
can be summarized as follows. (i) H2O2 is formed at substantially
higher NADH concentrations, and sigmoidal dependence on the sub-
strate concentration is evident (Fig. 3) with half-maximal activity at
25 μM (compare with apparent KmNADH of 0.5 μM in superoxide produc-
tion in Fig. 6B). (ii) In contrast to superoxide, hydrogen peroxide gen-
eration is essentially insensitive to high NADH concentration. This
ﬁnding agrees poorly with the proposed explanation of the inhibito-
ry effect of NADH on ROS production as shielding of the enzyme reac-
tive center (presumably FMNH–) by bound nucleotide, thus decreasing
its oxygen accessibility [62]. (iii) The redox titration of NADH-
supported H2O2 production (Fig. 4A) is well ﬁtted to a Nernst equation
for a two-electron/one proton oxidoreduction with ambient (NAD+/
NADH) midpoint potential of −347 mV at pH 8.0, a value
substantially more negative than that for superoxide production
(Fig. 4B).
It should be noted that FMNH−was suggested as the site of super-
oxide, not hydrogen peroxide, production by the bovine heart com-
plex I puriﬁed by an alternative procedure [52]. This proposal was
based on the redox proﬁle of superoxide generation ﬁtted to the
Nernst equation with ambient (NAD+/NADH) midpoint potential
of approximately −360 mV at pH 8.0 (see Fig. 5 in Ref [24]). Also,
it has been noted, in apparent contradiction with the data reported
here, that puriﬁed bovine heart complex I generates 95% ROS as su-
peroxide, whereas E. coli NDH-1, the prokaryotic homolog of complex
I, produces 20% O
·
2 and 80% H2O2 during NADH-supported ROS genera-
tion [63]. The reasons for different results reported here and those
obtained by others are not clear. Different experimental systems were
used: bovine heart SMP and traditional complex I (this paper) and
detergent-dispersed pure complex I [24] and SMP [25] prepared by an al-
ternative procedure. Another, perhaps more signiﬁcant, difference is thatROS production by SMP only at low concentration of NADH (30 μM)was
analyzed by Pryde and Hirst [25], whereas partitioning of the products
depends on NADH concentration (Fig. 2C and D).
Both superoxide and hydrogen peroxide productions are sensitive
to NAD+ [12] and NAD+/NADH ratio ([8,22,24,25,27] and this paper).
On the other hand, NADH oxidase activity catalyzed by complex I is
only weakly inhibited (competitively) by NAD+ (KNAD
þ
i is in millimo-
lar range [43]). A plausible explanation for this apparent discrepancy
most likely rests upon overall kinetics of NADH:ubiquinone reduction
in the respiratory chain catalyzed by complex I. Reoxidation of iron–
sulfur center N-2 is evidently the rate-limiting step during the
coupled or uncoupled steady-state NADH oxidase reaction [21,35].
As expected from the redox gap between the FMN/FMNH– and
N-2ox/N-2red couples, the N-2 center remains mostly in the reduced
form even when FMN is substantially oxidized (by the NAD+/NADH
couple), and the activities where FMNH− directly participates are
inhibited.
In summary, we interpret our data on ROS production by complex
I either in forward or reverse electron transfer as the presence of at
least two different sites directly reacting with oxygen in complex I lo-
cated upstream of the rotenone sensitive site: Site 1, most likely fully
reduced FMN where oxygen reduction via a two-electron mechanism
results in hydrogen peroxide formation, and Site 2, one of the iron–
sulfur centers, most likely N-2, where one-electron reduction results
in superoxide production.
Short note concerning physiological relevance of the data reported
worth noting. The concentration of NADH required for half-maximal
ROS production (0.5 μM and 25 μM for superoxide and hydrogen per-
oxide, respectively) are well below the physiologically relevant
values. An average content of NADH+NAD+ in heart mitochondria
is in a range of 5–7 nmol/mg of protein [64–66], the values corre-
sponding to 5–7 mM concentration in matrix (assuming 1 mg of pro-
tein corresponds to approximately 1 μl of water [67,68]). Although
substantial part of this nucleotide pool may be bound to matrix
located dehydrogenase it seems certain that complex I in intact mito-
chondria is always saturated by either NADH or NAD+. Since super-
oxide production is inhibited by high physiologically relevant
concentrations of NADH and/or NAD+ ([12], this paper), hydrogen
peroxide is expected to be the predominant species of ROS generated
by complex I.
4.3. Stimulation of ROS production by guanidine
Guanidine has long been known to modulate catalytic activities of
complex I [31,32]. In this study, we conﬁrmed the opposite effects of
guanidine on HAR (inhibition) and ferricyanide (activation) reductase
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no signiﬁcant effects on other major catalytic activities, NADH oxidase
and quinone reductase, were found. Both superoxide and hydrogen
peroxide production by complex I was activated by guanidine
(Table 3). Only the maximal rate was increased with no change in
KmNADH when the superoxide production rate hyperbolic dependence
on NADHwasmeasured (Fig. 6B). The redox titration curve in the pres-
ence of guanidine was shifted to more positive ambient redox potential
set up by NAD+/NADH ratio for hydrogen peroxide (Fig. 4A and B).
This can be interpreted as an increase in the redox potential of the
FMN/FMNH– couple resulting from interaction of reduced ﬂavin
anion with guanidine cation, as discussed by Sled et al. [33], assuming
that FMNH– is the electron donor for hydrogen peroxide production.
The stimulatory effect of guanidine on ferricyanide reduction can be
explained by an increase in semiquinone fraction observed upon
redox titration of complex I [33] if ﬂavin semiquinone participates
during the steady-state ferricyanide reduction.
Direct interaction of oxygen with complex I is likely a “leakage”
reaction, so no speciﬁc channels created during evolution to facilitate
the accessibility of the enzyme redox component to oxygen exist in
the protein structure, in contrast to true oxidases [69,70] or oxygen
carrying proteins [71,72]. The existence of at least two leakage “sites”
producing different products (H2O2 and O
·
2 ) as evident from the data
reported here is not unexpected. Accumulated evidence strongly sug-
gest that FMN is one such site. The reduction of ﬂavin in a FP fragment
[73] and in membrane-bound complex I [74] results in drastic change
of its binding to the protein, leading to dissociation if the system is
properly diluted. Redox-dependent rearrangement of FMN may serve
as a driving force for long-distance conformational change of the entire
structure of complex I that would change accessibility of iron–sulfur
clusters for oxygen that diffuses through the protein. The conforma-
tional ﬂexibility of complex I structure is well documented [75–77].
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